We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAA
3401
DELISTED
IAA, Inc. Common Stock
IAA
-1,762,833
Closed -$70.5M
VPCBW
3402
CALL
DELISTED
VPC Impact Acquisition Holdings II Warrant
VPCBW
-300,000
Closed -$3.03M
GXII
3403
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
-1,499,883
Closed -$15M
GXIIW
3404
CALL
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
-330,000
Closed -$3.3M
BGSX
3405
DELISTED
Build Acquisition Corp.
BGSX
-883,818
Closed -$8.86M
KSI
3406
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
-657,719
Closed -$6.6M
SMIH
3407
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
-593,899
Closed -$5.99M
FTPA
3408
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
-1,231,314
Closed -$12.4M
FRON
3409
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
-550,114
Closed -$5.55M
FTPAW
3410
CALL
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
-130,864
Closed -$1.31M
FRONW
3411
CALL
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
-127,645
Closed -$1.29M
LEGA
3412
DELISTED
Lead Edge Growth Opportunities, Ltd Class A Ordinary Shares
LEGA
-1,055,968
Closed -$10.7M
LEGAW
3413
CALL
DELISTED
Lead Edge Growth Opportunities, Ltd Warrant
LEGAW
-237,493
Closed -$2.4M
TBSA
3414
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
-899,985
Closed -$9.08M
TBSAW
3415
CALL
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
-299,995
Closed -$3.03M
AGGRW
3416
CALL
DELISTED
Agile Growth Corp Warrant
AGGRW
-399,997
Closed -$4.04M
ACQRW
3417
CALL
DELISTED
Independence Holdings Corp. Warrant
ACQRW
-279,997
Closed -$2.83M
CLAA
3418
DELISTED
Colonnade Acquisition Corp. II
CLAA
-1,431,353
Closed -$14.4M
CLAA.WS
3419
CALL
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
-125,344
Closed -$1.26M
ACQR
3420
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
-2,100,302
Closed -$21.2M
AGGR
3421
DELISTED
Agile Growth Corp
AGGR
-1,458,108
Closed -$14.7M
PDOT.WS
3422
CALL
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
-242,956
Closed -$2.47M
PDOT
3423
DELISTED
Peridot Acquisition Corp. II
PDOT
-1,985,007
Closed -$20.1M
PTOC
3424
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
-1,688,385
Closed -$17.1M
PTOCW
3425
CALL
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
-543,686
Closed -$5.49M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.